Aspira Women’s Health Inc. (AWH) is scheduled to report 3rd quarter earnings on 11/14/2024, before the market opens.
Regarding Q3 estimates, Wall Street analysts expect Aspira Women’s Health Inc. to post earnings of -$0.26 per share. Revenue expectations are pegged at $2.78 million. Last quarter, Aspira Women’s Health Inc. beat earnings estimates, reporting EPS of -$0.28 on estimates of -$0.31. The stock fell by -3.54% the day after the last earnings release.
Year-to-date, AWH stock has fallen by -78.95%.
About Aspira Women’s Health Inc.
Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company’s bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion was founded on December 9, 1993 and is headquartered in Austin, TX.
Stay up-to-date on earnings this week, with TipRanks’ Earnings Calendar.
